Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medifast Inc (NY: MED )

18.81 +0.23 (+1.24%)
Official Closing Price Updated: 7:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 206,343
Open 18.58
Bid (Size) 18.51 (2)
Ask (Size) 19.25 (1)
Prev. Close 18.58
Today's Range 18.53 - 19.22
52wk Range 17.07 - 76.42
Shares Outstanding 11,616,233
Dividend Yield 35.09%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Medifast (NYSE:MED) Posts Better-Than-Expected Sales In Q3 But Quarterly Guidance Underwhelms
Wellness company Medifast (NYSE:MED) reported Q3 CY2024 results exceeding the market’s revenue expectations, but sales fell 40.6% year on year to $140.2 million. On the other hand, next quarter’s... 
Via StockStory
Medifast Announces Third Quarter 2024 Financial Results
From Medifast
Via Business Wire

Performance

YTD
-73.22%
-73.22%
1 Month
+1.29%
+1.29%
3 Month
-9.83%
-9.83%
6 Month
-25.30%
-25.30%
1 Year
-73.38%
-73.38%

More News

Read More
Medifast (MED) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024
From Medifast
Via Business Wire
Looking Into Medifast's Recent Short Interest
Via Benzinga
MED Stock Earnings: Medifast Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Medifast Announces Second Quarter 2024 Financial Results
From Medifast
Via Business Wire
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024
From Medifast, Inc.
Via Business Wire
(MED) - Analyzing Medifast's Short Interest
Via Benzinga
Time to Unload: 3 Stocks in Deep Trouble to Sell Now
Via InvestorPlace
7 Consumer Staples Stocks to Buy at a 52-Week Low in July
Via InvestorPlace
3 Overlooked Telehealth Stocks Poised for a Comeback
Via InvestorPlace
Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
Via InvestorPlace
Medifast Named as One of The “Best Companies To Work For” by U.S. News & World Report
From Medifast
Via Business Wire
3 Stocks to Sell as Ozempic Surges in Popularity
Via InvestorPlace
7 Small-Cap Value Stocks Leaving the S&P 500 in the Dust
Via InvestorPlace
Topics Stocks
Exposures US Equities
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
7 Underappreciated Stocks With 25% Return Potential in 2024
Via InvestorPlace
LifeMD Can Surge on Its GLP-1 Offerings
Via MarketBeat
Invest in the Underestimated: 7 Bargain Stocks Poised to Prove Wall Street Wrong
Via InvestorPlace
Medifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications
From Medifast
Via Business Wire
Pocket-Sized Powerhouses: 7 Small-Cap Value Stocks Ready to Roar
Via InvestorPlace
Top 4 Defensive Stocks You'll Regret Missing This Quarter
Via Benzinga
Gold Down Over 2%; 3M Profit Beats Expectations
Via Benzinga
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.